Author Archives: Rabita Aziz

World Health Assembly 2019: Failures persist in DRC Ebola outbreak responses, leaders say

By on .

GENEVA – While international agencies identify violence and community mistrust as the main reasons the Ebola outbreak in the Democratic Republic of the Congo remains uncontrolled, here DRC Minister of Health Dr. Oly Ilunga Kalenga identified gaps in communication, data and planning as additional weaknesses preventing effective responses. “We need to emerge from silos,” he […]

World Health Assembly 2019: No universal health coverage without better access to medicines, health ministers say

By on .

GENEVA – The vision of universal health coverage dominates the discussions at the 72nd World Health Organization gathering, to the point that initials are considered sufficient — UHC — to argue its importance. Still, the goal remains far out of reach without greatly improved access to medicines, diagnostic tools and vaccines, health ministers said here […]

CUGH 2019: Researchers say training, resources for the “private sector,” including traditional healers, will be critical to TB control

By on .

CHICAGO – To find the missing tuberculosis cases that go unreported each year, national TB programs will have to reach out to the places where the most people seek care, researchers said here. And that’s not in public hospitals or clinics where capacities to respond to TB already exist, but in the private sector in […]

CROI 2019: Two “game changing regimens” together show promise for preventing TB in people living with HIV

By on .

SEATTLE – A new and shorter drug regimen to prevent tuberculosis illness can safely be given to people with HIV who are on antiretroviral treatment regimens that include dolutegravir, researchers here announced. The finding is good news for people living with HIV for two reasons. The new regimen – consisting of the TB drugs isoniazid […]

CROI 2019: Point-of-care viral load testing improves HIV outcomes, researchers say

By on .

SEATTLE – People living with HIV who undergo HIV viral load testing at the point of health care delivery and receive their results immediately go on to achieve undetectable viral loads at higher rates than people whose  testing is done at laboratories, researchers said here. Results from the Simplifying HIV Treatment and Monitoring – or […]

CROI 2019: Thailand’s strides spanned HIV treatment, prevention and research

By on .

SEATTLE – The first HIV vaccine trials to yield signs of hope happened here. Thailand was also the first Asian country to eliminate mother-to-child transmission of HIV. Now, Thailand has achieved the first part of UNAIDS’ 90-90-90 targets: 98 percent of people infected with HIV know their status. Of that, 70 percent are receiving HIV […]

49th Union World Conference on Lung Health: 90 percent of participants in short-course XDR-TB regimen cured after six months

By on .

THE HAGUE, Netherlands – New results from the ongoing Nix-TB trial continue to confirm a short-course treatment regimen of bedaquiline – one of the two newest drugs to treat TB in half a century – linezolid and pretomanid offers a significantly improved treatment option for people infected with drug resistant forms of tuberculosis, researchers said […]

49th Union World Conference on Lung Health: Integrating HIV treatment and TB preventative therapy greatly improves IPT adherence

By on .

THE HAGUE, Netherlands – When tuberculosis preventive therapy is delivered with HIV treatment services and patients get a choice in where they access treatment, completion of tuberculosis preventive therapy rises, helping to ensure people living with HIV stay healthy, researchers said here. This model of prevention should be scaled up in TB-HIV high burden settings, researchers […]

49th Union World Conference on Lung Health: Activists call for price drop on MDR-TB drug

By on .

THE HAGUE, Netherlands – Attendees here observed a minute of silence on Thursday in remembrance of an 18-year-old girl in India who died two weeks ago from multidrug-resistant tuberculosis. She died, treatment advocates explained, because she couldn’t access bedaquiline, a drug that received regulatory approval five years before she needed it. Among attendees here joining the […]